Joben Bio-Medical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Joben Bio-Medical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients (NCT02289365) | Joben Bio-Medical Co., Ltd. | 2014-11-01 |
Track Joben Bio-Medical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.